There have been more delays at Surface Transforms.
The carbon fibre brake discs developer says some revenues will be delayed until 2019-2020 or later. This is mainly due to the customer known as OEM 6, but the value of the contracts has not changed.
Forecast revenues for the year to May 2019 have been halved to £1m. Surface Transforms was expected to make a 2018-19 loss of £1.9m, compared with £2.2m in 2017-18, but the forecast loss has been increased to £2.7m.
Surface Transforms recently raised £1.9m at 15.5p a share. The share price has fallen to 11.5p.
© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Omega Diagnostics will lose money this year, but it is on course to become profitable in 2020-21 as sales of the VISITECT CD4 test.
House broker Shore Capital has slashed its pre-tax profit forecast for engineer Tricorn Group by two-thirds to £420,000.
Evgen Pharma has entered into an agreement with The University of Dundee for the use of SFX-01 in a clinical trial in non-alcoholic steatohepatitis and liver fibrosis, where there is no existing treatment.